Ana M C De Jesus-Acosta

9PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 11, 2026
Comprehensive Somatic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms.

|May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.

Parul Agarwal, Matthew Guo, Kabeer Munjal

|May 19, 2025
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson, Won Jin Ho, Daniel Shu

|Sep 04, 2024
Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice.

Ana De Jesus-Acosta, Chirayu Mohindroo

|Apr 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.

Chirayu Mohindroo, Seyda Baydogan, Parul Agarwal

|Aug 30, 2023
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer.

H Catherine Wilbur, Jennifer N Durham, Su Jin Lim

Pageof 2

Frequent Collaborators

6 joint publications

Daniel Laheru

4 joint publications

Katherine M Bever

4 joint publications

Jennifer N Durham

4 joint publications

Elizabeth M Jaffee